Trade Summary

4 days ago, Verma Abhimanyu, serving as Chief Technology Officer at SOPHiA GENETICS SA (SOPH), sold 5,000 shares at $7.60 per share, for a total transaction value of $38,000.00. Following this transaction, Verma Abhimanyu now holds 182,171 shares of SOPH.

This sale represents a 2.67% decrease in Verma Abhimanyu's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, August 7, 2026 and publicly disclosed via SEC Form 4 filing on Monday, August 10, 2026 at 5:14 PM ET, 3 days after the trade was made.

SOPHiA GENETICS SA operates in the HEALTHCARE sector, specifically within the HEALTH INFORMATION SERVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.